Cargando…
Expediting approval for medical countermeasures to address high burden disease: an ethical justification to move beyond emergency use authorisation
Addressing global health crises requires a receptive and expedient policy environment to minimise delays in making available potentially life-saving technologies. Over time, the policy environment has adapted to ensure that communities have expedited access to promising technologies, such as vaccine...
Autores principales: | Mercuri, Mathew, Hackett, Kristy, Upshur, Ross, Emerson, Claudia Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626867/ https://www.ncbi.nlm.nih.gov/pubmed/37918871 http://dx.doi.org/10.1136/bmjgh-2023-013480 |
Ejemplares similares
-
Adolescent wellbeing in humanitarian and fragile settings: moving beyond rhetoric
por: Singh, Neha S, et al.
Publicado: (2023) -
Institutionalising community engagement for quality of care: moving beyond the rhetoric
por: Gilmore, Brynne, et al.
Publicado: (2023) -
The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018
por: Schuster Bruce, Catherine, et al.
Publicado: (2019) -
Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?
por: Petersen, Sesilje B, et al.
Publicado: (2021) -
Between rules and resistance: moving public health emergency responses beyond fear, racism and greed
por: Jackson, Carly, et al.
Publicado: (2022)